Breakthrough in Vision Restoration Through Optogenetics
Millions of individuals worldwide are affected by vision loss caused by retinal degenerative diseases, such as retinitis pigmentosa (RP) and
Read moreMillions of individuals worldwide are affected by vision loss caused by retinal degenerative diseases, such as retinitis pigmentosa (RP) and
Read moreIn vitro mammalian cells such as Caco-2 or MDCKII, crucial for preclinical research and drug discovery, are highly challenging to
Read morePlasma protein binding is a phenomenon where drugs bind to proteins in the blood, thereby reducing the concentration of free,
Read moreWuXi Biologics, a prominent global Contract Research, Development, and Manufacturing Organization (CRDMO), announced today, a new partnership with Candid Therapeutics,
Read moreCacoReady, a Useful Cell Model to Predict Drug-Induced Gastrointestinal Toxicity A ReadyCell .pdf Case Study – Author: Marta Olle Monge,
Read moreRenal elimination of drugs: The role of kidney transporters A ReadyCell .pdf White Paper – Author: Lourdes Gombau, R&D Director
Read moreGroundbreaking Research Highlights ipRGCs as Promising Biomarkers for Neurodegenerative Diseases A Striatech .pdf Case Study OptoDrum plays a key role
Read moreNew Research Highlights the Potential of Vitamin C in Protecting Vision for Glaucoma Patients A Striatech .pdf Case Study OptoDrum,
Read moreThe cutting-edge AcuiSee device for visual acuity testing of laboratory animals stands out as a breakthrough in the realm of
Read moreThe GERBU Adjuvant MTM is developed specifically for monoclonal antibody production and offers a high yield of IgG and fused
Read more